Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CXorf21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FTHL17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NR0B1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAGEB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAGEB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAGEB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAGEB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL1RAPL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DMD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on